Interestingly, inhibition of PGAM or any enzyme downstream of PGAM alone induced modest cardiac hypertrophy, even without overexpression of YAP, suggesting that intermediate products of the glycolytic pathway between F6P and PEP may be involved in YAP-induced cardiac hypertrophy (Figure 7C). The gene discussed is YAP1; the disease is cardiac hypertrophy.